Héroux-Devtek Inc. (TSE:HRX - Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$25.40 and traded as high as C$32.07. Héroux-Devtek shares last traded at C$32.00, with a volume of 21,431 shares traded.
Separately, TD Securities lowered Héroux-Devtek from a "buy" rating to a "sell" rating and boosted their price target for the company from C$28.00 to C$32.50 in a research note on Friday, July 12th.
View Our Latest Research Report on Héroux-Devtek
The stock has a fifty day moving average of C$31.40 and a two-hundred day moving average of C$25.40. The company has a current ratio of 2.14, a quick ratio of 0.96 and a debt-to-equity ratio of 48.49. The stock has a market capitalization of C$1.08 billion, a price-to-earnings ratio of 23.19, a PEG ratio of 1.02 and a beta of 1.73.
Héroux-Devtek (TSE:HRX - Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported C$0.39 earnings per share for the quarter, beating analysts' consensus estimates of C$0.26 by C$0.13. Héroux-Devtek had a return on equity of 11.18% and a net margin of 7.07%. The company had revenue of C$174.00 million during the quarter, compared to analyst estimates of C$159.00 million. As a group, equities research analysts forecast that Héroux-Devtek Inc. will post 1.5813492 earnings per share for the current year.
Héroux-Devtek Inc engages in the design, development, manufacture, finishing, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company serves commercial and defence sectors of the aerospace market.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Héroux-Devtek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Héroux-Devtek wasn't on the list.
While Héroux-Devtek currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.